SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Computers - Software >

Grey Cloak Tech (GRCK)

GRCK RSS Feed
Add GRCK Price Alert      Hide Sticky   Hide Intro
Moderator: Papa Bear, Carjockey2, sjoseph, maz1978 , FollowTheProfits, dipANDrip
Search This Board: 
Last Post: 12/14/2017 3:53:12 PM - Followers: 174 - Board type: Free - Posts Today: 32


Social Media Links - Click Below
Image result for twitter iconImage result for facebook iconImage result for linkedin icon
 
 

Grey Cloak Tech Announces Q2 Results, Continues to Seek Acquisition Candidates

 

Las Vegas, Nevada (PRWEB) September 07, 2016

For the second quarter of 2016, revenues were $41,250 for the three months ended June 30, 2016, compared to $34,800 for the three months ended June 30, 2015, an increase of $6,450, or 19%. Revenues were $80,250 for the six months ended June 30, 2016, compared to $45,400 for the six months ended June 30, 2015, an increase of $34,850, or 77%. Net operating loss was $64,425 for the three months ended June 30, 2016, compared to $107,416 for the three months ended June 30, 2015, a decrease of $42,991. Net loss was $108,796 for the three months ended June 30, 2016, or $0.01 per share, compared to $107,388 for the three months ended June 30, 2015, or $0.01 per share, an increase of $1,408. The $0.01 loss per share is based on a total of 15,290,849 outstanding shares as of June 30 2016.

Grey Cloak's revenues were generated through sales of their debut product, Fraudlytic, which continues to serve key customers across a variety of sectors including telecom, retail, and the automotive industry. Fraudlytic was developed to combat the increasing threat of digital advertising fraud - also known as bot fraud or click fraud - which the Interactive Advertising Bureau (IAB) projects could cost unsuspecting advertisers $8.2 billion annually. More recently, research conducted by the World Federation of Advertisers (WFA) projected the cost could exceed $50 billion a year by 2025.

To stay ahead of the threat, Grey Cloak continues to improve upon their core product. Version 2.0 of the product was rolled out in early August. Updates to the Fraudlytic software included performance improvements and better data tracking.

"The company is excited about Fraudlytic's advancements, and we're looking forward to adding products to our portfolio that are able to leverage the Fraudlytic technology," says Fred Covely, CEO of Grey Cloak, "the company will continue to improve on its current click fraud detection software, develop other suites of software, and explore other software products through possible acquisitions."

Forward-Looking Statements

Safe Harbor Notice 
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Grey Cloak Tech Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Grey Cloak Tech Inc. undertakes no obligation to revise these statements following the date of this news release.

For more information, visit http://www.greycloaktech.com.

Read the full story at http://www.prweb.com/releases/2016/09/prweb13660747.htm

 

 
Grey Cloak develops advanced software to overcome the most costly online security threats, including digital advertising fraud. Our mission is to revolutionize internet security by overcoming one threat at a time.
 
Image result for click fraud


 
Image result for click fraud Our debut cloud-based product, Fraudlytic, detects, tracks, and eliminates digital advertising fraud, a problem the Interactive Advertising Bureau (IAB) projects will cost unsuspecting advertisers $8.2 billion annually. As digital advertising is poised to overtake television advertising by 2019, according to PwC, the cost of online fraud threatens to grow exponentially. 


"Our mission is to revolutionize internet security by overcoming one threat at a time."

 


 

Fraudlytic™ is a cloud-based, secure platform that monitors internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and buy.
 
The click-fraud phenomena is costing digital advertisers billions of dollars and to date there is only one way to stop it: effective detection and elimination software.
 
Grey Cloak Tech founders have deep roots in the digital marketing industry and observed this problem many years ago. Combining with internet security specialists and the best programmers in this field, Grey Cloak Tech set out to stop the malicious viruses (bots) that not only cause false clicks, but infect computers worldwide with other destructive elements.
 
Like a laser-guided weapon, Fraudlytic™ detects, analyzes, and destroys bots while allowing legitimate consumer traffic to click and view digital ads.

 

fraudlytic-bold_600x400 - Copy
Image result for click fraud

 
 


 

Impression Fraud: Click fraud is ever evolving via manipulations of impressions. Grey Shield applies state-of-the-art, ever evolving detection programming to swiftly analyze and prohibit:

 

Masked URLs
Cookie Hijacking
Device Hijacking
IP Spoofing
Domain ID Theft
Ad Stacking



Doorway Site Detection: Search engine “doorways” are artificial web pages that redirect visitors without their knowledge by cloaking their actual URLs. Grey Shield’s landing page auditor penetrates false doorways and permanently bars them from your potential customers.

 

Self Programmable SAAS solution: Reduce IT costs with Grey Shield’s easy-to-set-up campaigns that provide detailed reports based on users behavior or on the campaign level. It will tell you which marketing campaigns are effective and which are fraudulent so they can get a predictable ROI. You can either block the bad traffic so it never reaches your website or you can see it in the reporting and make your marketing decisions on future campaigns, phones, tablets, and laptops.
Grey Shield’s Arsenal of Algorithms Include:


 

Digital Fingerprinting
Advanced Geo Detection services
Pattern Recognition
Bot & Virus Infection Detection
Proxy Network IP Surveillance
Domain Masking Detection



Graceful Interface: Grey Cloak’s API integrates seamlessly into your analytics programs, Programmatic or RTB Networks, and Google, Yahoo, and AOL.

 

Geo Location Feature: Your ads run specific to the location of the device. For example, as a traveler changes states, his device will adjust your ad accordingly where he might see a different ad or be redirected to another website.

Non-approved States: Screen out non-approved states from specific ad campaigns from showing in states that are not approved for that product.

Target marketing: This functionality also allows you to geographically target your ad compaigns. You can determine a geographical radius corresponding to a store location or desirable zip code market.


 





AS is 500M PER NVSOS AND THE OS IS 140M as per latest Q filing on 11/15/17

Approximately $160K max in notes remaining with over $500k paid off


http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=Qp9lqrf8wRxAOc01e881UA%253d%253d&nt7=0





RS- REVERSE SPLIT that was approved for anytime before the end of 2017 was CANCELLED per PR from CEO

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11887464 

 
Quote:
To approve an amendment to our Articles of Incorporation to 

effect a reverse stock split of our common stock at a ratio up to 1-for-

100, the exact ratio and timing of which will be set by our Board of

Directors at a future date no later than December 31,2017. 

The agenda item passed with votes as follows: 

For: 10,833,873 
Against: 370,762 
Abstain: 3,100 
Percentage Approving: 63.1% 

 
EQOVA LIFE SCIENCES Started their business per

NVSOS on AUGUST 1, 2017














LETTER OF INTENT SIGNED TO ACQUIRE EQOVA LIFE SCIENCES WITH AN ESTIMATED CLOSE OF 10/10/2017 PER GRCK CEO

https://eqova.com/

 

Eqova Life Sciences CEO 
 

Eqova Life Sciences’
Executive Team

Eqova’s management team brings 40 years of experience in the health product space. With sprawling expertise in functional medicine, product formulation, branding, direct sales, health practitioner partnerships and regulation & compliance.

Patrick Stiles

Co-Founder & CEO

Patrick is a serial entrepreneur who has spent most of the last decade working with Ph.D.s the world over to bring to market cutting edge health products that can transform people’s lives.

He is personally responsible for building numerous multi-million-dollar consumer health brands, helping thousands of people form dozens of countries with some of their most pressing health concerns.

He is a health startup veteran and expert in product formulation and health branding.

When Patrick isn’t working tirelessly to further his professional passions, you can find him salsa dancing with his wife, hiking in the Colorado Rockies, traveling internationally, volunteering with incarcerated youths or working on his own health with functional medicine.

Matthew Grabau

Co-Founder & CMO

Matt has grown a several nutraceutical ventures into multi-million-dollar operations from start-up. In his tenure with Eqova, he has been instrumental in operational development from concept to current day, serving a central role in the creation of the company’s proprietary business model, procuring raw material and personnel for start-up, establishing relationships with distributors and sales personnel, securing patented delivery systems and overseeing sales operations.

Previously, Matt was the CEO of Rocky Mountain Pro Nutrients. It was here that he and his team of sales representatives were responsible for growing one of the nation’s premier professional nutraceutical business from inception to $5 million in less than four years. His organization generated an average year-over-year growth of 270%, building towards a monthly volume of over 24,000 units.

Matt holds a Bachelor of Science degree from University of Northern Colorado and enjoys time with his wife and 3 children.

Dr. Paul Dragul

Chief Medical Officer

Dr. Dragul has spent over 4 decades studying and practicing medicine. He’s focused on bringing innovative new techniques and health practices to his patients. His greatest pride is helping people live healthier, happier lives.

He received his Ph.D. with Honors in Pharmacology & M.D. from the University of Cincinnati. He practiced at the United States Public Health Service & as the General Medical Officer for the Indian Hospital in Gallup New Mexico before practicing privately in Colorado.

Jesse Cothran

Compliance

With over 17 years of experience in the industry, Jesse Cothran is a dietary supplement expert. He has helped numerous companies expand business operations into more than 55 countries internationally and navigate through various federal, state, and foreign regulatory and quality requirements. Having started his career in a call center and eventually working his way up to become an executive, he is known for understanding the industry inside and out and helping companies build multi-million dollar businesses where quality and compliance are an integral part of the corporate culture.

 

Why Eqova Life Sciences?

Our Mission is to change the health of people the world over with safe, effective and standardized full spectrum hemp oil health products through their trusted professional medical health practitioners.

Cannabinoid Rich Health Supplements are powerful tools. Many people in the general public know this. And demand this benefits for their own health.



 
 

Eqova’s Mission & Core Values

Eqova Life Sciences, Inc. is the world’s very first full spectrum hemp oil brand exclusively created for medical practitioners.

 

Our Mission

is to change the health of people the world over with safe, effective and standardized full spectrum hemp oil health products through their trusted professional medical health practitioners.

Cannabinoid Rich Health Supplements are powerful tools. Many people in the general public know this, and demand these benefits for their own health.

But nothing is more effective than a holistic approach to modern medicine. Incorporating the very best of the western healthcare model with natural solutions when and where appropriate.

 

Eqova Believes

the most effective and safe application of full spectrum hemp oil health products is under the care and guidance of a medical practitioner.

This may allow regular people to achieve extraordinary health.

Because core regular people can achieve vibrant health without always resulting to prescription drugs or surgeries.

No one knows their patients’ health like the medical professionals who work with them to improve it.



NO MODS ARE TO DELETE, ALTER or DO ANYTHING ABOVE THIS.  IF YOU WANT TO ADD CONTENT PLEASE DO SO BELOW PER THE IHUB TOS.  

**I ADVISE ALL TO STOP RESPONDING TO "CERTAIN" POSTERS OR PLACE THEM ON IGNORE. THE BACK AND FORTH ONLY CLOGS THE BOARD AND PROVIDES NO NEW INSIGHT OR OPINION. LET THEM TALK TO THEMSELVES AND IF PLACED ON IGNORE YOU DON'T EVEN HAVE TO SEE THAT. WISH EVERYONE THE BEST OF LUCK AND THIS IS JUST A SUGGESTION. I FEEL LIKE THIS IS THE BEST COURSE OF ACTION TO COMBAT THE INTENTIONALLY IDIOTIC BACK AND FORTH.**

 

SureTrader
Interactive Brokers Advertisement
GRCK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GRCK News: Current Report Filing (8-k) 11/20/2017 05:07:45 PM
GRCK News: Quarterly Report (10-q) 11/15/2017 05:03:47 PM
GRCK News: Proxy Statement (definitive) (def 14a) 11/15/2017 04:02:44 PM
GRCK News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 11/15/2017 01:26:33 PM
GRCK News: Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) 11/03/2017 05:10:33 PM
PostSubject
#11834  Sticky Note CBD.co introductory video via CEO Patrick Stiles FollowTheProfits 11/27/17 08:11:51 AM
#11352  Sticky Note $GRCK DD, must read Recently acquired Eqova.com, a Clinical-grade KeepItRealistic 11/17/17 11:37:01 PM
#8487  Sticky Note Grey Cloak Tech Clarifies Reverse Split threewheeler 10/26/17 03:27:52 PM
#12954   Will do. It took them a few days FollowTheProfits 12/14/17 03:53:11 PM
#12953   I agree with you,let us know if you Dvanajscak 12/14/17 03:52:12 PM
#12952   I just sent grey cloak one a few FollowTheProfits 12/14/17 03:50:31 PM
#12951   are people trying to write mails to Patrick,or Dvanajscak 12/14/17 03:43:13 PM
#12950   I aint watching last two days after that Dvanajscak 12/14/17 03:35:46 PM
#12949   Too gory to watch INFINITI 12/14/17 03:16:39 PM
#12948   Bloody Red, UG Tadaaa 12/14/17 03:08:14 PM
#12947   We will be testing 1's within 2 weeks. IMO Maniana 12/14/17 02:42:23 PM
#12946   Wrong responder...I was addressing another poster so your Masala 12/14/17 02:12:15 PM
#12945   looking good. We may have eaten through enough FollowTheProfits 12/14/17 01:35:01 PM
#12944   What risk in holding a penny stock ? Really ? LMFAO KeepItRealistic 12/14/17 01:02:07 PM
#12943   That's all good ...though there are big big Masala 12/14/17 12:57:53 PM
#12942   Long as it stays I. The triangle Batman412 12/14/17 12:17:51 PM
#12941   Ok I'll check back later. BluSkies 12/14/17 11:57:16 AM
#12940   I like your numbers KeepItRealistic 12/14/17 11:30:51 AM
#12939   I said looking didn’t say it was INFINITI 12/14/17 11:29:15 AM
#12938   I have been doing my best to keep Mfbosox 12/14/17 11:21:19 AM
#12937   really...scam is a very loose word thrown around FollowTheProfits 12/14/17 11:18:19 AM
#12936   I stopped counting when I noticed i was KeepItRealistic 12/14/17 11:16:56 AM
#12934   Any idea how much is left? Orko 12/14/17 11:02:26 AM
#12933   Hate to say it but this is looking INFINITI 12/14/17 10:53:00 AM
#12932   Agree Just wish they had come earlier before KeepItRealistic 12/14/17 10:51:48 AM
#12931   If they are smart about it they will cal mo 12/14/17 10:50:28 AM
#12930   Need an update soon imo BluSkies 12/14/17 10:37:45 AM
#12929   they came in to pump it for that FollowTheProfits 12/14/17 10:33:58 AM
#12928   Depressing INFINITI 12/14/17 10:19:07 AM
#12927   Where did everybody go? Lol Orko 12/14/17 09:59:21 AM
#12926   CBD.co, 11 Trading Days till Launch ! Tadaaa 12/14/17 09:31:10 AM
#12925   Patience is killing me here hope its worth it INFINITI 12/14/17 08:33:46 AM
#12924   GRCK is pending an Eqova update followed by BluSkies 12/14/17 07:04:01 AM
#12923   5 million crosstrade @ .0035 on Tue + jujufumpkins 12/14/17 06:24:27 AM
#12922   Isn't Patrick the CEO running eqova which is Masala 12/13/17 08:54:19 PM
#12921   Days 18 Launching in 2017 https://cbd.co What happen BluSkies 12/13/17 07:45:11 PM
#12920   OS is under 200 million Today was dump KeepItRealistic 12/13/17 04:48:04 PM
#12919   Yah that's your 1 billion shares buddy BluSkies 12/13/17 03:56:11 PM
#12918   Why do they bother getting VNDM and BMIC i_like_bb_stock 12/13/17 03:53:13 PM
#12917   BMIC at 41 KeepItRealistic 12/13/17 03:48:52 PM
#12916   Still really good volume today ratting up those BluSkies 12/13/17 03:45:47 PM
#12915   Allready left the building lol 1 day p&d We don’t KeepItRealistic 12/13/17 03:11:02 PM
#12914   Flipping is a good thing. Never hold station1111 12/13/17 01:56:26 PM
#12913   https://postimg.org/image/imaqdnxxn/ My bad here Batman412 12/13/17 01:28:05 PM
#12912   [url=https://postimg.org/image/imaqdnxxn/]https://s33.postimg.org/imaqdnxxn Batman412 12/13/17 01:24:56 PM
#12911   It was a technical bounce from the low. BluSkies 12/13/17 01:11:30 PM
#12910   too funny, this stock has less than 200M Backstabbed 12/13/17 12:54:31 PM
#12909   100% from here back at .01 easy imo BluSkies 12/13/17 12:52:41 PM
#12908   So thin... t8rX 12/13/17 12:46:19 PM
#12907   Need to hold 004 today BluSkies 12/13/17 12:36:27 PM
#12906   It looks better but we are far from Dvanajscak 12/13/17 12:00:32 PM
#12905   This looks ready BluSkies 12/13/17 11:44:57 AM
#12904   Yup achron 12/13/17 11:16:38 AM
PostSubject